<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-LSN2IY0K</identifier><date>2017</date><creator>Grašič-Kuhar, Cvetka</creator><relation>documents/doc/L/URN_NBN_SI_doc-LSN2IY0K_001.pdf</relation><relation>documents/doc/L/URN_NBN_SI_doc-LSN2IY0K_001.txt</relation><format format_type="issue">2</format><format format_type="volume">21</format><format format_type="type">article</format><format format_type="extent">str. 6-11</format><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="COBISSID_HOST">2843771</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-LSN2IY0K</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">imunoterapija</subject><subject language_type_id="slv">protitumorski imunski cikel</subject><subject language_type_id="slv">stimulatorni signali</subject><title>Mesto imunoterapije pri zdravljenju raka</title><title>Role of immunotherapy in cancer treatment</title></Record>